Experimental and pharmacoinformatic approaches unveil the neuropharmacological and analgesic potential of chloroform fraction of Roktoshirinchi (Achyranthes ferruginea Roxb.)

Achyranthes ferruginea (A. ferruginea) Roxb. is a common plant used in traditional medicine in Asia and Africa. It has a variety of local names, including “Gulmanci” in Nigeria, “Dangar” in Pakistan, “Thola” in Ethiopia, and “Roktoshirinchi” in Bangladesh. It is edible and has several ethnomedical u...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of ethnopharmacology 2024-04, Vol.324, p.117769-117769, Article 117769
Hauptverfasser: Reza, A.S.M. Ali, Raihan, Riaj, Azam, Saidul, Shahanewz, Mohammed, Nasrin, Mst Samima, Siddique, Md Abu Bakar, Uddin, Md Nazim, Dey, Anik Kumar, Sadik, Md Golam, Alam, AHM Khurshid
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 117769
container_issue
container_start_page 117769
container_title Journal of ethnopharmacology
container_volume 324
creator Reza, A.S.M. Ali
Raihan, Riaj
Azam, Saidul
Shahanewz, Mohammed
Nasrin, Mst Samima
Siddique, Md Abu Bakar
Uddin, Md Nazim
Dey, Anik Kumar
Sadik, Md Golam
Alam, AHM Khurshid
description Achyranthes ferruginea (A. ferruginea) Roxb. is a common plant used in traditional medicine in Asia and Africa. It has a variety of local names, including “Gulmanci” in Nigeria, “Dangar” in Pakistan, “Thola” in Ethiopia, and “Roktoshirinchi” in Bangladesh. It is edible and has several ethnomedical uses for a wide range of illnesses, including hysteria, dropsy, constipation, piles, boils, asthma, and shigellosis. However, the neuropharmacological and analgesic potential of A. ferruginea remains uninvestigated. To assess the neuropharmacological and analgesic potential of A. ferruginea through a multifaceted approach encompassing both experimental and computational models. Methanol was used to extract the leaves of A. ferruginea. It was then fractionated with low to high polar solvents (n-hexane, chloroform, ethyl acetate, and water) to get different fractions, including chloroform fraction (CLF). The study selected CLF at different doses and conducted advanced chemical element and proximate analyses, as well as phytochemical profiling using GC-MS. Toxicological studies were done at 300 μg per rat per day for 14 days. Cholinesterase inhibitory potential was checked using an in-vitro colorimetric assay. Acetic acid-induced writhing (AAWT) and formalin-induced licking tests (FILT) were used to assess anti-nociceptive effects. The forced swim test (FST), tail suspension test (TST), elevated plus maze (EPM), hole board test (HBT), and light and dark box test (LDB) were among the behavioral tests used to assess depression and anxiolytic activity. Network pharmacology-based analysis was performed on selected compounds using the search tool for interacting chemicals-5 (STITCH 5), Swiss target prediction tool, and search tool for the retrieval of interacting genes and proteins (STRING) database to link their role with genes involved in neurological disorders through gene ontology and reactome analysis. Qualitative chemical element analysis revealed the presence of 15 elements, including Na, K, Ca, Mg, P, and Zn. The moisture content, ash value, and organic matter were found to be 11.12, 11.03, and 88.97%, respectively. GC-MS data revealed that the CLF possesses 25 phytoconstituents. Toxicological studies suggested the CLF has no effects on normal growth, hematological and biochemical parameters, or cellular organs after 14 days at 300 μg per rat. The CLF markedly reduced the activity of both acetylcholinesterase and butyrylcholinesterase (IC50: 56.22 and 13.22 μg/mL
doi_str_mv 10.1016/j.jep.2024.117769
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3153180113</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0378874124000680</els_id><sourcerecordid>3153180113</sourcerecordid><originalsourceid>FETCH-LOGICAL-c268t-bd63480cf519bed84d168d18727f6e6a3a6df4edb65350a6837a553b77aeba1d3</originalsourceid><addsrcrecordid>eNqFkcFu1DAURSMEokPhA9igLNtFgh0ntkesqqpApUpICNbWi_0y8ZCxg-1U7U_xjTiaaZewsvV03rF8b1G8p6SmhPKP-3qPc92Qpq0pFYJvXxQbKkVTiU6wl8WGMCErKVp6VryJcU8IEbQlr4szJhu6lZJvij83DzMGe0CXYCrBmXIeIRxAe-sGny_J6hLmOXjQI8ZycfdopzKNWDpcgn-iJ7-z-mQAB9MOY16cfcpim-d-KPU4-eBXaTkE0Ml6t46_-1_Jx9EG6_Roy4srPT4GcGl9bcAQlp11CBl76OvLt8WrAaaI707nefHz882P66_V3bcvt9dXd5VuuExVbzhrJdFDR7c9GtkayqVZoxEDRw4MuBlaND3vWEeASyag61gvBGAP1LDz4uLozR__vWBM6mCjxmkCh36JitGOUUkoZf9Fmy1tm66RQmaUHlEdfIwBBzXn6CE8KkrU2qjaq9yoWhtVx0bzzoeTfukPaJ43nirMwKcjgDmPe4tBRW3RaTQ2oE7KePsP_V8dFLZa</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2914252878</pqid></control><display><type>article</type><title>Experimental and pharmacoinformatic approaches unveil the neuropharmacological and analgesic potential of chloroform fraction of Roktoshirinchi (Achyranthes ferruginea Roxb.)</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Reza, A.S.M. Ali ; Raihan, Riaj ; Azam, Saidul ; Shahanewz, Mohammed ; Nasrin, Mst Samima ; Siddique, Md Abu Bakar ; Uddin, Md Nazim ; Dey, Anik Kumar ; Sadik, Md Golam ; Alam, AHM Khurshid</creator><creatorcontrib>Reza, A.S.M. Ali ; Raihan, Riaj ; Azam, Saidul ; Shahanewz, Mohammed ; Nasrin, Mst Samima ; Siddique, Md Abu Bakar ; Uddin, Md Nazim ; Dey, Anik Kumar ; Sadik, Md Golam ; Alam, AHM Khurshid</creatorcontrib><description>Achyranthes ferruginea (A. ferruginea) Roxb. is a common plant used in traditional medicine in Asia and Africa. It has a variety of local names, including “Gulmanci” in Nigeria, “Dangar” in Pakistan, “Thola” in Ethiopia, and “Roktoshirinchi” in Bangladesh. It is edible and has several ethnomedical uses for a wide range of illnesses, including hysteria, dropsy, constipation, piles, boils, asthma, and shigellosis. However, the neuropharmacological and analgesic potential of A. ferruginea remains uninvestigated. To assess the neuropharmacological and analgesic potential of A. ferruginea through a multifaceted approach encompassing both experimental and computational models. Methanol was used to extract the leaves of A. ferruginea. It was then fractionated with low to high polar solvents (n-hexane, chloroform, ethyl acetate, and water) to get different fractions, including chloroform fraction (CLF). The study selected CLF at different doses and conducted advanced chemical element and proximate analyses, as well as phytochemical profiling using GC-MS. Toxicological studies were done at 300 μg per rat per day for 14 days. Cholinesterase inhibitory potential was checked using an in-vitro colorimetric assay. Acetic acid-induced writhing (AAWT) and formalin-induced licking tests (FILT) were used to assess anti-nociceptive effects. The forced swim test (FST), tail suspension test (TST), elevated plus maze (EPM), hole board test (HBT), and light and dark box test (LDB) were among the behavioral tests used to assess depression and anxiolytic activity. Network pharmacology-based analysis was performed on selected compounds using the search tool for interacting chemicals-5 (STITCH 5), Swiss target prediction tool, and search tool for the retrieval of interacting genes and proteins (STRING) database to link their role with genes involved in neurological disorders through gene ontology and reactome analysis. Qualitative chemical element analysis revealed the presence of 15 elements, including Na, K, Ca, Mg, P, and Zn. The moisture content, ash value, and organic matter were found to be 11.12, 11.03, and 88.97%, respectively. GC-MS data revealed that the CLF possesses 25 phytoconstituents. Toxicological studies suggested the CLF has no effects on normal growth, hematological and biochemical parameters, or cellular organs after 14 days at 300 μg per rat. The CLF markedly reduced the activity of both acetylcholinesterase and butyrylcholinesterase (IC50: 56.22 and 13.22 μg/mL, respectively). Promising dose-dependent analgesic activity (p &lt; 0.05) was observed in chemically-induced pain models. The TST and FST showed a dose-dependent substantial reduction in immobility time due to the CLF. Treatment with CLF notably increased the number of open arm entries and time spent in the EPM test at doses of 200 and 400 mg/kg b.w. The CLF showed significant anxiolytic activity at 200 mg/kg b.w. in the HBT test, whereas a similar activity was observed at 400 mg/kg b.w. in the EPM test. A notable increase in the amount of time spent in the light compartment was observed in the LDB test by mice treated with CLF, suggesting an anxiolytic effect. A network pharmacology study demonstrated the relationship between the phytochemicals and a number of targets, such as PPARA, PPARG, CHRM1, and HTR2, which are connected to the shown bioactivities. This study demonstrated the safety of A. ferruginea and its efficacy in attenuating cholinesterase inhibitory activity, central and peripheral pain, anxiety, and depression, warranting further exploration of its therapeutic potential. [Display omitted] •A. ferruginea has a traditional use in ailments, including dropsy, hysteria, etc.•A. ferruginea has neuropharmacological and analgesic potential.•GC-MS-identified compounds linked to bioactive targets via network pharmacology.</description><identifier>ISSN: 0378-8741</identifier><identifier>EISSN: 1872-7573</identifier><identifier>DOI: 10.1016/j.jep.2024.117769</identifier><identifier>PMID: 38219886</identifier><language>eng</language><publisher>Ireland: Elsevier B.V</publisher><subject>Acetylcholinesterase ; Achyranthes ; Analgesic ; analgesic effect ; Analgesics - adverse effects ; Animals ; Anti-Anxiety Agents - adverse effects ; Antidepressants ; anxiety ; Anxiolytics ; asthma ; Bangladesh ; Butyrylcholinesterase ; chemical constituents of plants ; Chloroform ; cholinesterase ; Cholinesterase inhibition ; colorimetry ; constipation ; dose response ; edema ; Ethiopia ; ethyl acetate ; forced swimming test ; gene ontology ; hexane ; methanol ; Mice ; Nigeria ; organic matter ; Pain ; Pain - chemically induced ; Pain - drug therapy ; Pakistan ; peroxisome proliferator-activated receptor alpha ; peroxisome proliferator-activated receptor gamma ; phytochemicals ; Plant Extracts - therapeutic use ; Plant Extracts - toxicity ; prediction ; Rats ; shigellosis ; tail suspension test ; therapeutics ; toxicology ; traditional medicine ; tranquilizers ; water content</subject><ispartof>Journal of ethnopharmacology, 2024-04, Vol.324, p.117769-117769, Article 117769</ispartof><rights>2024 Elsevier B.V.</rights><rights>Copyright © 2024 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c268t-bd63480cf519bed84d168d18727f6e6a3a6df4edb65350a6837a553b77aeba1d3</cites><orcidid>0000-0001-7947-1910 ; 0000-0003-2690-6559</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0378874124000680$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38219886$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Reza, A.S.M. Ali</creatorcontrib><creatorcontrib>Raihan, Riaj</creatorcontrib><creatorcontrib>Azam, Saidul</creatorcontrib><creatorcontrib>Shahanewz, Mohammed</creatorcontrib><creatorcontrib>Nasrin, Mst Samima</creatorcontrib><creatorcontrib>Siddique, Md Abu Bakar</creatorcontrib><creatorcontrib>Uddin, Md Nazim</creatorcontrib><creatorcontrib>Dey, Anik Kumar</creatorcontrib><creatorcontrib>Sadik, Md Golam</creatorcontrib><creatorcontrib>Alam, AHM Khurshid</creatorcontrib><title>Experimental and pharmacoinformatic approaches unveil the neuropharmacological and analgesic potential of chloroform fraction of Roktoshirinchi (Achyranthes ferruginea Roxb.)</title><title>Journal of ethnopharmacology</title><addtitle>J Ethnopharmacol</addtitle><description>Achyranthes ferruginea (A. ferruginea) Roxb. is a common plant used in traditional medicine in Asia and Africa. It has a variety of local names, including “Gulmanci” in Nigeria, “Dangar” in Pakistan, “Thola” in Ethiopia, and “Roktoshirinchi” in Bangladesh. It is edible and has several ethnomedical uses for a wide range of illnesses, including hysteria, dropsy, constipation, piles, boils, asthma, and shigellosis. However, the neuropharmacological and analgesic potential of A. ferruginea remains uninvestigated. To assess the neuropharmacological and analgesic potential of A. ferruginea through a multifaceted approach encompassing both experimental and computational models. Methanol was used to extract the leaves of A. ferruginea. It was then fractionated with low to high polar solvents (n-hexane, chloroform, ethyl acetate, and water) to get different fractions, including chloroform fraction (CLF). The study selected CLF at different doses and conducted advanced chemical element and proximate analyses, as well as phytochemical profiling using GC-MS. Toxicological studies were done at 300 μg per rat per day for 14 days. Cholinesterase inhibitory potential was checked using an in-vitro colorimetric assay. Acetic acid-induced writhing (AAWT) and formalin-induced licking tests (FILT) were used to assess anti-nociceptive effects. The forced swim test (FST), tail suspension test (TST), elevated plus maze (EPM), hole board test (HBT), and light and dark box test (LDB) were among the behavioral tests used to assess depression and anxiolytic activity. Network pharmacology-based analysis was performed on selected compounds using the search tool for interacting chemicals-5 (STITCH 5), Swiss target prediction tool, and search tool for the retrieval of interacting genes and proteins (STRING) database to link their role with genes involved in neurological disorders through gene ontology and reactome analysis. Qualitative chemical element analysis revealed the presence of 15 elements, including Na, K, Ca, Mg, P, and Zn. The moisture content, ash value, and organic matter were found to be 11.12, 11.03, and 88.97%, respectively. GC-MS data revealed that the CLF possesses 25 phytoconstituents. Toxicological studies suggested the CLF has no effects on normal growth, hematological and biochemical parameters, or cellular organs after 14 days at 300 μg per rat. The CLF markedly reduced the activity of both acetylcholinesterase and butyrylcholinesterase (IC50: 56.22 and 13.22 μg/mL, respectively). Promising dose-dependent analgesic activity (p &lt; 0.05) was observed in chemically-induced pain models. The TST and FST showed a dose-dependent substantial reduction in immobility time due to the CLF. Treatment with CLF notably increased the number of open arm entries and time spent in the EPM test at doses of 200 and 400 mg/kg b.w. The CLF showed significant anxiolytic activity at 200 mg/kg b.w. in the HBT test, whereas a similar activity was observed at 400 mg/kg b.w. in the EPM test. A notable increase in the amount of time spent in the light compartment was observed in the LDB test by mice treated with CLF, suggesting an anxiolytic effect. A network pharmacology study demonstrated the relationship between the phytochemicals and a number of targets, such as PPARA, PPARG, CHRM1, and HTR2, which are connected to the shown bioactivities. This study demonstrated the safety of A. ferruginea and its efficacy in attenuating cholinesterase inhibitory activity, central and peripheral pain, anxiety, and depression, warranting further exploration of its therapeutic potential. [Display omitted] •A. ferruginea has a traditional use in ailments, including dropsy, hysteria, etc.•A. ferruginea has neuropharmacological and analgesic potential.•GC-MS-identified compounds linked to bioactive targets via network pharmacology.</description><subject>Acetylcholinesterase</subject><subject>Achyranthes</subject><subject>Analgesic</subject><subject>analgesic effect</subject><subject>Analgesics - adverse effects</subject><subject>Animals</subject><subject>Anti-Anxiety Agents - adverse effects</subject><subject>Antidepressants</subject><subject>anxiety</subject><subject>Anxiolytics</subject><subject>asthma</subject><subject>Bangladesh</subject><subject>Butyrylcholinesterase</subject><subject>chemical constituents of plants</subject><subject>Chloroform</subject><subject>cholinesterase</subject><subject>Cholinesterase inhibition</subject><subject>colorimetry</subject><subject>constipation</subject><subject>dose response</subject><subject>edema</subject><subject>Ethiopia</subject><subject>ethyl acetate</subject><subject>forced swimming test</subject><subject>gene ontology</subject><subject>hexane</subject><subject>methanol</subject><subject>Mice</subject><subject>Nigeria</subject><subject>organic matter</subject><subject>Pain</subject><subject>Pain - chemically induced</subject><subject>Pain - drug therapy</subject><subject>Pakistan</subject><subject>peroxisome proliferator-activated receptor alpha</subject><subject>peroxisome proliferator-activated receptor gamma</subject><subject>phytochemicals</subject><subject>Plant Extracts - therapeutic use</subject><subject>Plant Extracts - toxicity</subject><subject>prediction</subject><subject>Rats</subject><subject>shigellosis</subject><subject>tail suspension test</subject><subject>therapeutics</subject><subject>toxicology</subject><subject>traditional medicine</subject><subject>tranquilizers</subject><subject>water content</subject><issn>0378-8741</issn><issn>1872-7573</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkcFu1DAURSMEokPhA9igLNtFgh0ntkesqqpApUpICNbWi_0y8ZCxg-1U7U_xjTiaaZewsvV03rF8b1G8p6SmhPKP-3qPc92Qpq0pFYJvXxQbKkVTiU6wl8WGMCErKVp6VryJcU8IEbQlr4szJhu6lZJvij83DzMGe0CXYCrBmXIeIRxAe-sGny_J6hLmOXjQI8ZycfdopzKNWDpcgn-iJ7-z-mQAB9MOY16cfcpim-d-KPU4-eBXaTkE0Ml6t46_-1_Jx9EG6_Roy4srPT4GcGl9bcAQlp11CBl76OvLt8WrAaaI707nefHz882P66_V3bcvt9dXd5VuuExVbzhrJdFDR7c9GtkayqVZoxEDRw4MuBlaND3vWEeASyag61gvBGAP1LDz4uLozR__vWBM6mCjxmkCh36JitGOUUkoZf9Fmy1tm66RQmaUHlEdfIwBBzXn6CE8KkrU2qjaq9yoWhtVx0bzzoeTfukPaJ43nirMwKcjgDmPe4tBRW3RaTQ2oE7KePsP_V8dFLZa</recordid><startdate>20240424</startdate><enddate>20240424</enddate><creator>Reza, A.S.M. Ali</creator><creator>Raihan, Riaj</creator><creator>Azam, Saidul</creator><creator>Shahanewz, Mohammed</creator><creator>Nasrin, Mst Samima</creator><creator>Siddique, Md Abu Bakar</creator><creator>Uddin, Md Nazim</creator><creator>Dey, Anik Kumar</creator><creator>Sadik, Md Golam</creator><creator>Alam, AHM Khurshid</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7S9</scope><scope>L.6</scope><orcidid>https://orcid.org/0000-0001-7947-1910</orcidid><orcidid>https://orcid.org/0000-0003-2690-6559</orcidid></search><sort><creationdate>20240424</creationdate><title>Experimental and pharmacoinformatic approaches unveil the neuropharmacological and analgesic potential of chloroform fraction of Roktoshirinchi (Achyranthes ferruginea Roxb.)</title><author>Reza, A.S.M. Ali ; Raihan, Riaj ; Azam, Saidul ; Shahanewz, Mohammed ; Nasrin, Mst Samima ; Siddique, Md Abu Bakar ; Uddin, Md Nazim ; Dey, Anik Kumar ; Sadik, Md Golam ; Alam, AHM Khurshid</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c268t-bd63480cf519bed84d168d18727f6e6a3a6df4edb65350a6837a553b77aeba1d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Acetylcholinesterase</topic><topic>Achyranthes</topic><topic>Analgesic</topic><topic>analgesic effect</topic><topic>Analgesics - adverse effects</topic><topic>Animals</topic><topic>Anti-Anxiety Agents - adverse effects</topic><topic>Antidepressants</topic><topic>anxiety</topic><topic>Anxiolytics</topic><topic>asthma</topic><topic>Bangladesh</topic><topic>Butyrylcholinesterase</topic><topic>chemical constituents of plants</topic><topic>Chloroform</topic><topic>cholinesterase</topic><topic>Cholinesterase inhibition</topic><topic>colorimetry</topic><topic>constipation</topic><topic>dose response</topic><topic>edema</topic><topic>Ethiopia</topic><topic>ethyl acetate</topic><topic>forced swimming test</topic><topic>gene ontology</topic><topic>hexane</topic><topic>methanol</topic><topic>Mice</topic><topic>Nigeria</topic><topic>organic matter</topic><topic>Pain</topic><topic>Pain - chemically induced</topic><topic>Pain - drug therapy</topic><topic>Pakistan</topic><topic>peroxisome proliferator-activated receptor alpha</topic><topic>peroxisome proliferator-activated receptor gamma</topic><topic>phytochemicals</topic><topic>Plant Extracts - therapeutic use</topic><topic>Plant Extracts - toxicity</topic><topic>prediction</topic><topic>Rats</topic><topic>shigellosis</topic><topic>tail suspension test</topic><topic>therapeutics</topic><topic>toxicology</topic><topic>traditional medicine</topic><topic>tranquilizers</topic><topic>water content</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Reza, A.S.M. Ali</creatorcontrib><creatorcontrib>Raihan, Riaj</creatorcontrib><creatorcontrib>Azam, Saidul</creatorcontrib><creatorcontrib>Shahanewz, Mohammed</creatorcontrib><creatorcontrib>Nasrin, Mst Samima</creatorcontrib><creatorcontrib>Siddique, Md Abu Bakar</creatorcontrib><creatorcontrib>Uddin, Md Nazim</creatorcontrib><creatorcontrib>Dey, Anik Kumar</creatorcontrib><creatorcontrib>Sadik, Md Golam</creatorcontrib><creatorcontrib>Alam, AHM Khurshid</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>AGRICOLA</collection><collection>AGRICOLA - Academic</collection><jtitle>Journal of ethnopharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Reza, A.S.M. Ali</au><au>Raihan, Riaj</au><au>Azam, Saidul</au><au>Shahanewz, Mohammed</au><au>Nasrin, Mst Samima</au><au>Siddique, Md Abu Bakar</au><au>Uddin, Md Nazim</au><au>Dey, Anik Kumar</au><au>Sadik, Md Golam</au><au>Alam, AHM Khurshid</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Experimental and pharmacoinformatic approaches unveil the neuropharmacological and analgesic potential of chloroform fraction of Roktoshirinchi (Achyranthes ferruginea Roxb.)</atitle><jtitle>Journal of ethnopharmacology</jtitle><addtitle>J Ethnopharmacol</addtitle><date>2024-04-24</date><risdate>2024</risdate><volume>324</volume><spage>117769</spage><epage>117769</epage><pages>117769-117769</pages><artnum>117769</artnum><issn>0378-8741</issn><eissn>1872-7573</eissn><abstract>Achyranthes ferruginea (A. ferruginea) Roxb. is a common plant used in traditional medicine in Asia and Africa. It has a variety of local names, including “Gulmanci” in Nigeria, “Dangar” in Pakistan, “Thola” in Ethiopia, and “Roktoshirinchi” in Bangladesh. It is edible and has several ethnomedical uses for a wide range of illnesses, including hysteria, dropsy, constipation, piles, boils, asthma, and shigellosis. However, the neuropharmacological and analgesic potential of A. ferruginea remains uninvestigated. To assess the neuropharmacological and analgesic potential of A. ferruginea through a multifaceted approach encompassing both experimental and computational models. Methanol was used to extract the leaves of A. ferruginea. It was then fractionated with low to high polar solvents (n-hexane, chloroform, ethyl acetate, and water) to get different fractions, including chloroform fraction (CLF). The study selected CLF at different doses and conducted advanced chemical element and proximate analyses, as well as phytochemical profiling using GC-MS. Toxicological studies were done at 300 μg per rat per day for 14 days. Cholinesterase inhibitory potential was checked using an in-vitro colorimetric assay. Acetic acid-induced writhing (AAWT) and formalin-induced licking tests (FILT) were used to assess anti-nociceptive effects. The forced swim test (FST), tail suspension test (TST), elevated plus maze (EPM), hole board test (HBT), and light and dark box test (LDB) were among the behavioral tests used to assess depression and anxiolytic activity. Network pharmacology-based analysis was performed on selected compounds using the search tool for interacting chemicals-5 (STITCH 5), Swiss target prediction tool, and search tool for the retrieval of interacting genes and proteins (STRING) database to link their role with genes involved in neurological disorders through gene ontology and reactome analysis. Qualitative chemical element analysis revealed the presence of 15 elements, including Na, K, Ca, Mg, P, and Zn. The moisture content, ash value, and organic matter were found to be 11.12, 11.03, and 88.97%, respectively. GC-MS data revealed that the CLF possesses 25 phytoconstituents. Toxicological studies suggested the CLF has no effects on normal growth, hematological and biochemical parameters, or cellular organs after 14 days at 300 μg per rat. The CLF markedly reduced the activity of both acetylcholinesterase and butyrylcholinesterase (IC50: 56.22 and 13.22 μg/mL, respectively). Promising dose-dependent analgesic activity (p &lt; 0.05) was observed in chemically-induced pain models. The TST and FST showed a dose-dependent substantial reduction in immobility time due to the CLF. Treatment with CLF notably increased the number of open arm entries and time spent in the EPM test at doses of 200 and 400 mg/kg b.w. The CLF showed significant anxiolytic activity at 200 mg/kg b.w. in the HBT test, whereas a similar activity was observed at 400 mg/kg b.w. in the EPM test. A notable increase in the amount of time spent in the light compartment was observed in the LDB test by mice treated with CLF, suggesting an anxiolytic effect. A network pharmacology study demonstrated the relationship between the phytochemicals and a number of targets, such as PPARA, PPARG, CHRM1, and HTR2, which are connected to the shown bioactivities. This study demonstrated the safety of A. ferruginea and its efficacy in attenuating cholinesterase inhibitory activity, central and peripheral pain, anxiety, and depression, warranting further exploration of its therapeutic potential. [Display omitted] •A. ferruginea has a traditional use in ailments, including dropsy, hysteria, etc.•A. ferruginea has neuropharmacological and analgesic potential.•GC-MS-identified compounds linked to bioactive targets via network pharmacology.</abstract><cop>Ireland</cop><pub>Elsevier B.V</pub><pmid>38219886</pmid><doi>10.1016/j.jep.2024.117769</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0001-7947-1910</orcidid><orcidid>https://orcid.org/0000-0003-2690-6559</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0378-8741
ispartof Journal of ethnopharmacology, 2024-04, Vol.324, p.117769-117769, Article 117769
issn 0378-8741
1872-7573
language eng
recordid cdi_proquest_miscellaneous_3153180113
source MEDLINE; Elsevier ScienceDirect Journals
subjects Acetylcholinesterase
Achyranthes
Analgesic
analgesic effect
Analgesics - adverse effects
Animals
Anti-Anxiety Agents - adverse effects
Antidepressants
anxiety
Anxiolytics
asthma
Bangladesh
Butyrylcholinesterase
chemical constituents of plants
Chloroform
cholinesterase
Cholinesterase inhibition
colorimetry
constipation
dose response
edema
Ethiopia
ethyl acetate
forced swimming test
gene ontology
hexane
methanol
Mice
Nigeria
organic matter
Pain
Pain - chemically induced
Pain - drug therapy
Pakistan
peroxisome proliferator-activated receptor alpha
peroxisome proliferator-activated receptor gamma
phytochemicals
Plant Extracts - therapeutic use
Plant Extracts - toxicity
prediction
Rats
shigellosis
tail suspension test
therapeutics
toxicology
traditional medicine
tranquilizers
water content
title Experimental and pharmacoinformatic approaches unveil the neuropharmacological and analgesic potential of chloroform fraction of Roktoshirinchi (Achyranthes ferruginea Roxb.)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T19%3A06%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Experimental%20and%20pharmacoinformatic%20approaches%20unveil%20the%20neuropharmacological%20and%20analgesic%20potential%20of%20chloroform%20fraction%20of%20Roktoshirinchi%20(Achyranthes%20ferruginea%20Roxb.)&rft.jtitle=Journal%20of%20ethnopharmacology&rft.au=Reza,%20A.S.M.%20Ali&rft.date=2024-04-24&rft.volume=324&rft.spage=117769&rft.epage=117769&rft.pages=117769-117769&rft.artnum=117769&rft.issn=0378-8741&rft.eissn=1872-7573&rft_id=info:doi/10.1016/j.jep.2024.117769&rft_dat=%3Cproquest_cross%3E3153180113%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2914252878&rft_id=info:pmid/38219886&rft_els_id=S0378874124000680&rfr_iscdi=true